Shantanu Narayen transformed Adobe from a boxed-software maker into a cloud subscription powerhouse, growing revenue from $3 billion in 2007 to over $21 billion by 2024. Born in Hyderabad and educated ...

Agreement worth up to $495 million is part of a growing number of Chinese deals with global pharma giants as the country ...

Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences") today announced a strategic commercialization collaboration with Pfizer China for Ecnoglutide injection (Ecnoglutide), a new–generation ...

Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.

Liam Dunne is Co-founder and CEO of Klearcom, an Irish SaaS company that helps global brands monitor and improve IVR and ...

The list price of Wegovy will be cut in half on January 1, 2027, plummeting from around $1,350 to $675 a month. The cost of ...

A patient has died in a mid-stage study of MacroGenics’ bispecific antibody lorigerlimab in gynecologic cancers, prompting ...

New podcast season to spotlight P&L-focused leaders blazing the trail to purposeful procurement ...

Q4 2025 earnings call recap: pipeline milestones, PROTAC FDA/PDUFA timeline, 2026 data catalysts, and cash runway—read now.

Novo Nordisk's next-gen obesity drug CagriSema failed to match Eli Lilly's Zepbound in a head-to-head trial, sending shares ...

Protara Therapeutics has touted a 66% complete response (CR) rate for its cell therapy among certain bladder cancer patients ...

Fresh off a failed trial that sent its shares plummeting, Novo Nordisk said that one of its experimental obesity drugs helped patients lose nearly 20% of their weight after 24 weeks in a midstage tria ...